Literature DB >> 6176885

The possible existence of multiple receptors for substance P.

C M Lee, L L Iversen, M R Hanley, B E Sandberg.   

Abstract

1. The possible existence of multiple receptors for substance P (SP) was investigated by examining the relative pharmacological potencies of SP and related peptides in contracting guinea pig ileum, in potentiating electrically evoked contractions of rat vas deferens preparations and in competing for 3H-SP receptor binding in rat brain membranes, and by comparing the extent of cross-tachyphylaxis of various analogues with SP in the guinea pig ileum. 2. Different rank orders of potencies were observed among SP, its C-terminal fragments, analogues and related tachykinins in the different test systems, and these could not be explained by differential access to the target organ receptors. 3. In contrast to SP and physalaemin, both eledoisin and a metabolically stable SP analogue, [pGlu5, MePhe8, Sar9]-SP5-11 exhibited differential recovery from SP tachyphylaxis in the guinea pig ileum, and part of their spasmogenic action in this preparation was atropine-sensitive. 4. The results suggest the possible existence of multiple SP receptors, and the specificity of those in the brain may be different from those in the gut. The structural and pharmacological basis for subdividing tachykinins into SP-physalaemin and eledoisin-kassinin families is also discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6176885     DOI: 10.1007/BF00501166

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  31 in total

1.  An unidentified depressor substance in certain tissue extracts.

Authors:  U S V Euler; J H Gaddum
Journal:  J Physiol       Date:  1931-06-06       Impact factor: 5.182

2.  Interaction of physalaemin, substance P, and eledoisin with specific membrane receptors on pancreatic acinar cells.

Authors:  R T Jensen; J D Gardner
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

3.  [Crossed tachyphylaxis of peptides].

Authors:  F Lembeck; G Fischer
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1967

Review 4.  Substance P as a transmitter candidate.

Authors:  R A Nicoll; C Schenker; S E Leeman
Journal:  Annu Rev Neurosci       Date:  1980       Impact factor: 12.449

5.  Release of histamine by substance P.

Authors:  F Erjavec; F Lembeck; T Florjanc-Irman; G Skofitsch; J Donnerer; A Saria; P Holzer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-08       Impact factor: 3.000

6.  Synthesis and biological properties of enzyme-resistant analogues of substance P.

Authors:  B E Sandberg; C M Lee; M R Hanley; L L Iversen
Journal:  Eur J Biochem       Date:  1981-02

Review 7.  Active polypeptides of nonmammalian origin.

Authors:  G Bertaccini
Journal:  Pharmacol Rev       Date:  1976-06       Impact factor: 25.468

8.  The actions of some vasoactive polypeptides and their antagonists on the anococcygeus muscle.

Authors:  J S Gillespie; A T McKnight
Journal:  Br J Pharmacol       Date:  1978-02       Impact factor: 8.739

9.  Effect of neuropeptides on the efficiency of the peristaltic reflex.

Authors:  P Holzer; F Lembeck
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-07       Impact factor: 3.000

10.  Hypothalamic substance P as a candidate for transmitter of primary afferent neurons.

Authors:  M Otsuka; S Konishi; T Takahashi
Journal:  Fed Proc       Date:  1975-09
View more
  56 in total

1.  Differences in neurokinin receptor pharmacology between rat and guinea-pig superior cervical ganglia.

Authors:  G R Seabrook; M Main; B Bowery; N Wood; R G Hill
Journal:  Br J Pharmacol       Date:  1992-04       Impact factor: 8.739

2.  Pharmacological specificity of novel, synthetic, cyclic peptides as antagonists at tachykinin receptors.

Authors:  A T McKnight; J J Maguire; N J Elliott; A E Fletcher; A C Foster; R Tridgett; B J Williams; J Longmore; L L Iversen
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

3.  In vivo and in vitro actions of mammalian tachykinins.

Authors:  U Holzer-Petsche; E Schimek; R Amann; F Lembeck
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-08       Impact factor: 3.000

4.  Bronchoconstrictor and hypotensive effects in relation to pharmacokinetics of tachykinins in the guinea-pig--evidence for extraneuronal cleavage of neuropeptide K to neurokinin A.

Authors:  C R Martling; E Theodorsson-Norheim; I Norheim; J M Lundberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-08       Impact factor: 3.000

5.  An examination of the pharmacology of two substance P antagonists and the evidence for tachykinin receptor subtypes.

Authors:  S J Bailey; R L Featherstone; C C Jordan; I K Morton
Journal:  Br J Pharmacol       Date:  1986-01       Impact factor: 8.739

6.  A comparison of the effects of three substance P antagonists on tachykinin-stimulated [3H]-acetylcholine release in the guinea-pig ileum.

Authors:  R L Featherstone; P Fosbraey; I K Morton
Journal:  Br J Pharmacol       Date:  1986-01       Impact factor: 8.739

7.  Effect of inhaled substance P and neurokinin A on the airways of normal and asthmatic subjects.

Authors:  G Joos; R Pauwels; M van der Straeten
Journal:  Thorax       Date:  1987-10       Impact factor: 9.139

8.  Effects of interactions of naturally-occurring neuropeptides on blood flow in the rat knee joint.

Authors:  F Y Lam; W R Ferrell
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

9.  Mast cell deficient and neurokinin-1 receptor knockout mice are protected from stress-induced hair growth inhibition.

Authors:  Petra C Arck; Bori Handjiski; Arne Kuhlmei; Eva M J Peters; Maike Knackstedt; Anita Peter; Stephen P Hunt; Burghard F Klapp; Ralf Paus
Journal:  J Mol Med (Berl)       Date:  2005-03-10       Impact factor: 4.599

10.  Tachykininergic transmission to the circular muscle of the guinea-pig ileum: evidence for the involvement of NK2 receptors.

Authors:  L Bartho; P Santicioli; R Patacchini; C A Maggi
Journal:  Br J Pharmacol       Date:  1992-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.